Day: January 12, 2018

Marijuana Business Daily reporter John Schroyer is on the ground in California, posting firsthand accounts detailing the historic, Jan. 1 launch of the state’s recreational marijuana market. Scroll down for an inside account from cannabis business executives pioneering the state’s new adult-use market, which Marijuana Business Daily estimates will generate at least $4Continue Reading

With lineage tracing back to the long-renowned AJ’s Sour Diesel, this strain is best for socializing. In the last year, Sour Banana Sherbet has picked up major hype in Oregon. We reached out to Benjamin Nadolny of Fox Hollow Flora to get the story on their popular version of DNAContinue Reading

If you’re wondering whether you should bench your bud, take a look at some of these reasons why you may want to abstain from cannabis for a bit. The post 7 Signs It Might Be Time for a Break From Cannabis appeared first on Leafly. Read More: 7Continue Reading

Between boasting Colorado’s highest concentration of cannabis shops and offering a glitzy après-ski scene, Aspen puts its own spin on living the high life. The post The Cannabis Connoisseur’s Guide to the Ultimate Weekend in Aspen appeared first on Leafly. Read More: The Cannabis Connoisseur’s Guide to theContinue Reading

Medical cannabis advocates face a tough challenge. Senate Majority Floor Leader Damon Thayer later predicted such a bill wouldn’t garner enough votes to pass. The post Kentucky Medical Cannabis Bill Faces Uphill Fight appeared first on Leafly. Read More: Kentucky Medical Cannabis Bill Faces Uphill FightContinue Reading

Governor-elect Phil Murphy doesn’t succeed Chris Christie until next week, but already lawmakers are moving to achieve one of his campaign promises: legalizing marijuana. The post New Jersey Lawmakers Introduce Bill to Legalize Cannabis appeared first on Leafly. Read More: New Jersey Lawmakers Introduce Bill to Legalize CannabisContinue Reading

In a bold show of support for the hemp industry and CBD, 28 members of Congress are asking a federal appeals court to reject the Drug Enforcement Administration’s argument that cannabidiol is a Schedule 1 drug. The Congress members filed the brief Thursday in conjunction with a pending lawsuit against theContinue Reading